Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT
Bone Marrow Transplant. 2024 Mar 4. doi: 10.1038/s41409-024-02248-9.…
Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature
Ann Hematol. 2024 Mar 2. doi: 10.1007/s00277-024-05677-0. Online…
Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT)
Cytotherapy. 2024 Feb 17:S1465-3249(24)00054-9. doi: 10.1016/j.jcyt.2024.02.007.…
Selinexor, daratumumab, bortezomib and dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma: results of the phase II, non-randomized, multicenter GEM-SELIBORDARA study
Haematologica. 2024 Feb 15. doi: 10.3324/haematol.2023.284089.…
Axicabtagene ciloleucel versus tisagenlecleucel for relapsed or refractory large B-cell lymphoma: a systematic review and meta-analysis
Transplant Cell Ther. 2024 Jan 26:S2666-6367(24)00171-4. doi:…
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry
Ther Adv Med Oncol. 2024 Jan 18;16:17588359231225028. doi: 10.1177/17588359231225028.…
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
Nat Med. 2024 Jan 9. doi: 10.1038/s41591-023-02767-w. Online…
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Lancet Haematol. 2024 Jan 3:S2352-3026(23)00342-3. doi: 10.1016/S2352-3026(23)00342-3.…
Classical Hodgkin’s Lymphoma
2024 Apr 11. In: Sureda A, Corbacioglu S, Greco R, Kröger N,…
The EBMT: History, Present, and Future
2024 Apr 11. In: Sureda A, Corbacioglu S, Greco R, Kröger N,…
Graft Failure
2024 Apr 11. In: Sureda A, Corbacioglu S, Greco R, Kröger N,…
CAR T-cell therapy in aggressive lymphomas-identifying prognostic and predictive markers
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):357-363.…
